BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 219024)

  • 1. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
    Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
    Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
    Crane LR; Milne DA; Sunstrum JC; Lerner AM
    Antimicrob Agents Chemother; 1984 Oct; 26(4):557-62. PubMed ID: 6083754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral agents.
    Reines ED; Gross PA
    Med Clin North Am; 1988 May; 72(3):691-715. PubMed ID: 3280914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.
    Pulliam L; Panitch HS; Baringer JR; Dix RD
    Antimicrob Agents Chemother; 1986 Dec; 30(6):840-6. PubMed ID: 3028250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aranucleosides and aranucleotides in viral chemotherapy.
    North TW; Cohen SS
    Pharmacol Ther; 1979; 4(1):81-108. PubMed ID: 88745
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB; Bailey EJ; Lerner AM
    J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
    Gephart JF; Lerner AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG; Jones BR
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
    Bryson YJ; Connor JD
    Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-herpes activity of adenine arabinoside monophosphate.
    Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
    Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
    Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
    Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.